Analysis and Commentary STEVEN GROSSMAN 7/8/24 Analysis and Commentary STEVEN GROSSMAN 7/8/24 Past Analyses Provide Context for House and Senate Action on Ag-FDA Funding (Special Edition) Read More Advocacy at a Glance STEVEN GROSSMAN 6/21/24 Advocacy at a Glance STEVEN GROSSMAN 6/21/24 Looking Toward Full House Appropriations Committee Markup July 10 Read More Analysis and Commentary STEVEN GROSSMAN 6/21/24 Analysis and Commentary STEVEN GROSSMAN 6/21/24 Two Pathways for Saving FDA’s FY 25 Budget Read More Advocacy at a Glance STEVEN GROSSMAN 6/14/24 Advocacy at a Glance STEVEN GROSSMAN 6/14/24 House Agriculture/FDA Appropriations Subcommittee Approves FY 25 Ag/FDA Funding Bill Read More Analysis and Commentary STEVEN GROSSMAN 6/14/24 Analysis and Commentary STEVEN GROSSMAN 6/14/24 The Past is Prologue, But Subcommittee Bills May Not Be Read More Advocacy at a Glance STEVEN GROSSMAN 6/7/24 Advocacy at a Glance STEVEN GROSSMAN 6/7/24 Tentative Schedule for House Consideration of the Agriculture/FDA Appropriations Bill Read More Analysis and Commentary STEVEN GROSSMAN 6/7/24 Analysis and Commentary STEVEN GROSSMAN 6/7/24 What the FY 24 Appropriations Cycle Tells Us About FY 25 Read More Advocacy at a Glance STEVEN GROSSMAN 5/31/24 Advocacy at a Glance STEVEN GROSSMAN 5/31/24 The Alliance Continued Hill Days with Virtual Meetings Last Week Read More Analysis and Commentary STEVEN GROSSMAN 5/31/24 Analysis and Commentary STEVEN GROSSMAN 5/31/24 “Hurry Up and Wait” and Other Appropriations Questions Read More Advocacy at a Glance STEVEN GROSSMAN 5/17/24 Advocacy at a Glance STEVEN GROSSMAN 5/17/24 Virtual Hill Days Next Week, Following House and Senate Meetings the Last Two Weeks Read More Analysis and Commentary STEVEN GROSSMAN 5/17/24 Analysis and Commentary STEVEN GROSSMAN 5/17/24 Three Things We Heard in Senate-side Hill Meetings Read More Advocacy at a Glance STEVEN GROSSMAN 5/10/24 Advocacy at a Glance STEVEN GROSSMAN 5/10/24 Alliance Members Urged to Participate in Senate and Virtual Hill Days Read More Analysis and Commentary STEVEN GROSSMAN 5/10/24 Analysis and Commentary STEVEN GROSSMAN 5/10/24 Three Things We Heard in House-side Hill Meetings Read More Advocacy at a Glance STEVEN GROSSMAN 5/3/24 Advocacy at a Glance STEVEN GROSSMAN 5/3/24 FDA Before Senate Appropriations on Wednesday, May 8 Read More Analysis and Commentary STEVEN GROSSMAN 5/3/24 Analysis and Commentary STEVEN GROSSMAN 5/3/24 Q&A on the Urgent Need for FDA Advocacy Read More Advocacy at a Glance STEVEN GROSSMAN 4/26/24 Advocacy at a Glance STEVEN GROSSMAN 4/26/24 Alliance Members Urged to Participate in Upcoming Hill Days Read More Analysis and Commentary STEVEN GROSSMAN 4/26/24 Analysis and Commentary STEVEN GROSSMAN 4/26/24 Escaping the Downward Budget Pressures in FY 25 Read More Advocacy at a Glance STEVEN GROSSMAN 4/24/24 Advocacy at a Glance STEVEN GROSSMAN 4/24/24 Link to the Alliance’s Analysis of Final FY 24 Funding for the FDA Read More Advocacy at a Glance STEVEN GROSSMAN 4/19/24 Advocacy at a Glance STEVEN GROSSMAN 4/19/24 Alliance Releases FY 25 FDA Funding Ask Read More Analysis and Commentary STEVEN GROSSMAN 4/19/24 Analysis and Commentary STEVEN GROSSMAN 4/19/24 The Alliance’s FY 25 Ask: Urgent Initiatives That Need More Funding Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 7/8/24 Analysis and Commentary STEVEN GROSSMAN 7/8/24 Past Analyses Provide Context for House and Senate Action on Ag-FDA Funding (Special Edition) Read More
Advocacy at a Glance STEVEN GROSSMAN 6/21/24 Advocacy at a Glance STEVEN GROSSMAN 6/21/24 Looking Toward Full House Appropriations Committee Markup July 10 Read More
Analysis and Commentary STEVEN GROSSMAN 6/21/24 Analysis and Commentary STEVEN GROSSMAN 6/21/24 Two Pathways for Saving FDA’s FY 25 Budget Read More
Advocacy at a Glance STEVEN GROSSMAN 6/14/24 Advocacy at a Glance STEVEN GROSSMAN 6/14/24 House Agriculture/FDA Appropriations Subcommittee Approves FY 25 Ag/FDA Funding Bill Read More
Analysis and Commentary STEVEN GROSSMAN 6/14/24 Analysis and Commentary STEVEN GROSSMAN 6/14/24 The Past is Prologue, But Subcommittee Bills May Not Be Read More
Advocacy at a Glance STEVEN GROSSMAN 6/7/24 Advocacy at a Glance STEVEN GROSSMAN 6/7/24 Tentative Schedule for House Consideration of the Agriculture/FDA Appropriations Bill Read More
Analysis and Commentary STEVEN GROSSMAN 6/7/24 Analysis and Commentary STEVEN GROSSMAN 6/7/24 What the FY 24 Appropriations Cycle Tells Us About FY 25 Read More
Advocacy at a Glance STEVEN GROSSMAN 5/31/24 Advocacy at a Glance STEVEN GROSSMAN 5/31/24 The Alliance Continued Hill Days with Virtual Meetings Last Week Read More
Analysis and Commentary STEVEN GROSSMAN 5/31/24 Analysis and Commentary STEVEN GROSSMAN 5/31/24 “Hurry Up and Wait” and Other Appropriations Questions Read More
Advocacy at a Glance STEVEN GROSSMAN 5/17/24 Advocacy at a Glance STEVEN GROSSMAN 5/17/24 Virtual Hill Days Next Week, Following House and Senate Meetings the Last Two Weeks Read More
Analysis and Commentary STEVEN GROSSMAN 5/17/24 Analysis and Commentary STEVEN GROSSMAN 5/17/24 Three Things We Heard in Senate-side Hill Meetings Read More
Advocacy at a Glance STEVEN GROSSMAN 5/10/24 Advocacy at a Glance STEVEN GROSSMAN 5/10/24 Alliance Members Urged to Participate in Senate and Virtual Hill Days Read More
Analysis and Commentary STEVEN GROSSMAN 5/10/24 Analysis and Commentary STEVEN GROSSMAN 5/10/24 Three Things We Heard in House-side Hill Meetings Read More
Advocacy at a Glance STEVEN GROSSMAN 5/3/24 Advocacy at a Glance STEVEN GROSSMAN 5/3/24 FDA Before Senate Appropriations on Wednesday, May 8 Read More
Analysis and Commentary STEVEN GROSSMAN 5/3/24 Analysis and Commentary STEVEN GROSSMAN 5/3/24 Q&A on the Urgent Need for FDA Advocacy Read More
Advocacy at a Glance STEVEN GROSSMAN 4/26/24 Advocacy at a Glance STEVEN GROSSMAN 4/26/24 Alliance Members Urged to Participate in Upcoming Hill Days Read More
Analysis and Commentary STEVEN GROSSMAN 4/26/24 Analysis and Commentary STEVEN GROSSMAN 4/26/24 Escaping the Downward Budget Pressures in FY 25 Read More
Advocacy at a Glance STEVEN GROSSMAN 4/24/24 Advocacy at a Glance STEVEN GROSSMAN 4/24/24 Link to the Alliance’s Analysis of Final FY 24 Funding for the FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 4/19/24 Advocacy at a Glance STEVEN GROSSMAN 4/19/24 Alliance Releases FY 25 FDA Funding Ask Read More
Analysis and Commentary STEVEN GROSSMAN 4/19/24 Analysis and Commentary STEVEN GROSSMAN 4/19/24 The Alliance’s FY 25 Ask: Urgent Initiatives That Need More Funding Read More
